Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers.

In recent years, numerous delivery systems based on polymers, dendrimers, and nano-scale assemblies have been developed to improve the properties of drug molecules. In general, for the drug molecules to be active, they must be released from these delivery systems, ideally in a selective manner at the therapeutic target. As the changes in physiological conditions are relatively subtle from one tissue to another and the concentrations of specific enzymes are often quite low, a release strategy involving the amplification of a biological signal is particularly attractive. This article describes the development of oligomers, dendrimers, and linear polymers based on self-immolative spacers. This new class of molecules is designed to undergo a cascade of intramolecular reactions in response to the cleavage of a trigger moiety, resulting in molecular fragmentation and the release of multiple reporter or drug molecules. Progress in the development of these materials as drug delivery vehicles and sensors will be highlighted.

[1]  J. Chern,et al.  Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. , 2008, Journal of medicinal chemistry.

[2]  Richard A Lerner,et al.  Prodrug activation gated by a molecular "OR" logic trigger. , 2005, Angewandte Chemie.

[3]  P. Trail,et al.  (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin. , 1993, Bioconjugate chemistry.

[4]  H. W. Scheeren,et al.  Plasmin‐activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  A. Romieu,et al.  Chemiluminescent probe for the in vitro detection of protease activity. , 2007, Organic letters.

[6]  P. Ferruti,et al.  New poly(amidoamine)s containing disulfide linkages in their main chain , 2005 .

[7]  F. Szoka,et al.  A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas , 2006, Proceedings of the National Academy of Sciences.

[8]  D. Thompson,et al.  Comparative toxicity of eugenol and its quinone methide metabolite in cultured liver cells using kinetic fluorescence bioassays. , 1998, Toxicology and applied pharmacology.

[9]  Roey J. Amir,et al.  Receiver-amplifier, self-immolative dendritic device. , 2007, Chemistry.

[10]  W. Denny Hypoxia-activated prodrugs in cancer therapy: progress to the clinic. , 2010, Future oncology.

[11]  J. West,et al.  Thermo-responsive systems for controlled drug delivery. , 2008, Expert opinion on drug delivery.

[12]  Istvan J. Majoros,et al.  Dendrimer-Based Nanomedicine , 2008 .

[13]  C. Monneret,et al.  New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy. , 2006, Bioorganic & medicinal chemistry.

[14]  D. Shabat,et al.  Molecular probe for enzymatic activity with dual output. , 2007, Bioorganic & medicinal chemistry.

[15]  B. Jo,et al.  Polymer prodrug approaches applied to paclitaxel , 2010 .

[16]  Xiaobing Zhang,et al.  An autoimmolative spacer allows first-time incorporation of a unique solid-state fluorophore into a detection probe for acyl hydrolases. , 2010, Chemistry.

[17]  D. McGrath,et al.  Phototriggering of geometric dendrimer disassembly: An improved synthesis of 2,4-bis(hydroxymethyl)phenol based dendrimers , 2004 .

[18]  H. Kroemer,et al.  Elucidation of the mechanism enabling tumor selective prodrug monotherapy. , 1998, Cancer research.

[19]  S. Smith,et al.  Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole. , 1990, Journal of medicinal chemistry.

[20]  Ruixue Liu,et al.  Thermoresponsive copolymers: from fundamental studies to applications , 2009 .

[21]  A. Wahl,et al.  Protease-mediated fragmentation of p-amidobenzyl ethers: a new strategy for the activation of anticancer prodrugs. , 2002, The Journal of organic chemistry.

[22]  Jean M. J. Fréchet,et al.  Synthesis and Degradation of pH-Sensitive Linear Poly(amidoamine)s , 2007 .

[23]  Xianrui Zhao,et al.  Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release. , 2010, Bioconjugate chemistry.

[24]  Samir Mitragotri,et al.  Designer Biomaterials for Nanomedicine , 2009 .

[25]  J. Geffner,et al.  Extracellular acidification induces human neutrophil activation. , 1999, Journal of immunology.

[26]  C. H. Laycock The Receiver/Amplifier , 1976 .

[27]  D. Shabat,et al.  Enzymatic activation of hydrophobic self-immolative dendrimers: the effect of reporters with ionizable functional groups. , 2009, Bioorganic & medicinal chemistry letters.

[28]  L. Murray,et al.  Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  D. Kroll,et al.  Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues. , 2009, Bioconjugate chemistry.

[30]  D. Shabat,et al.  Self-immolative polymers. , 2008, Journal of the American Chemical Society.

[31]  Roey J. Amir,et al.  Self-immolative dendrimer biodegradability by multi-enzymatic triggering. , 2004, Chemical communications.

[32]  C. Monneret,et al.  Synthesis of self-immolative glucuronide spacers based on aminomethylcarbamate. Application to 5-fluorouracil prodrugs for antibody-directed enzyme prodrug therapy , 1999 .

[33]  A. Romieu,et al.  A HTS assay for the detection of organophosphorus nerve agent scavengers. , 2010, Chemistry.

[34]  F. Friedlos,et al.  Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme. , 1994, Journal of medicinal chemistry.

[35]  D. Kerr,et al.  Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Influence of the linker on the biodistribution and catabolism of actinium-225 self-immolative tumor-targeted isotope generators. , 2006, Bioconjugate chemistry.

[37]  R. Satchi‐Fainaro,et al.  Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier. , 2007, Bioorganic & medicinal chemistry.

[38]  J. P. Irigoyena,et al.  The plasminogen activator system : biology and regulation , 2022 .

[39]  H. Lode,et al.  Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2. , 2004, Journal of the American Chemical Society.

[40]  C. Allen,et al.  Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Roey J. Amir,et al.  Substituent-dependent disassembly of self-immolative dendrimers , 2007 .

[42]  R. Borchardt,et al.  Prodrug strategies based on intramolecular cyclization reactions. , 1997, Journal of pharmaceutical sciences.

[43]  D. Leeper,et al.  Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[44]  N. Murthy,et al.  A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers. , 2002, Journal of the American Chemical Society.

[45]  Jim Euchner Design , 2014, Catalysis from A to Z.

[46]  M. Wakselman THE 1,4 AND 1,6 ELIMINATIONS FROM HYDROXY‐ AND AMINO‐SUBSTITUTED BENZYL SYSTEMS: CHEMICAL AND BIOCHEMICAL APPLICATIONS , 1983 .

[47]  E. Gillies,et al.  Design, synthesis, and cyclization of 4-aminobutyric acid derivatives: potential candidates as self-immolative spacers. , 2011, Organic & biomolecular chemistry.

[48]  P. Baran,et al.  The pyridinone-methide elimination. , 2009, Organic & biomolecular chemistry.

[49]  Elizabeth R Gillies,et al.  A cascade biodegradable polymer based on alternating cyclization and elimination reactions. , 2009, Journal of the American Chemical Society.

[50]  J. Klafter,et al.  Two-component dendritic chain reactions: experiment and theory. , 2010, Journal of the American Chemical Society.

[51]  F. Kratz,et al.  Development of dual-acting prodrugs for circumventing multidrug resistance. , 2009, Bioorganic & medicinal chemistry letters.

[52]  Prodrug Strategies in Anticancer Chemotherapy , 2008, ChemMedChem.

[53]  Jean M. J. Fréchet,et al.  Dendrimers and other dendritic polymers , 2001 .

[54]  Simon A. Williams,et al.  Modulating paclitaxel bioavailability for targeting prostate cancer. , 2007, Bioorganic & medicinal chemistry.

[55]  P. Senter Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapy , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  Jean M. J. Fréchet,et al.  Development of acid-sensitive copolymer micelles for drug delivery , 2004 .

[57]  L. Tietze,et al.  Duocarmycin-based prodrugs for cancer prodrug monotherapy. , 2008, Bioorganic & medicinal chemistry.

[58]  Phil S Baran,et al.  Activity-linked labeling of enzymes by self-immolative polymers. , 2009, Bioconjugate chemistry.

[59]  Dendritic chain reaction: responsive release of hydrogen peroxide upon generation and enzymatic oxidation of methanol. , 2010, Bioorganic & medicinal chemistry.

[60]  L. Tietze,et al.  Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity. , 2010, Organic & biomolecular chemistry.

[61]  D. Shabat,et al.  Self-immolative comb-polymers: multiple-release of side-reporters by a single stimulus event. , 2008, Chemistry.

[62]  R. Satchi‐Fainaro,et al.  Real-time monitoring of drug release. , 2010, Chemical communications.

[63]  C. Monneret,et al.  Protecting groups for glucuronic acid: application to the synthesis of new paclitaxel (taxol) derivatives. , 2006, The Journal of organic chemistry.

[64]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[65]  Soong-Hoon Kim,et al.  Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid. , 2010, Bioorganic & medicinal chemistry letters.

[66]  A. Satyam Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker. , 2008, Bioorganic & medicinal chemistry letters.

[67]  R. Satchi‐Fainaro,et al.  Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel. , 2009, Bioorganic & medicinal chemistry.

[68]  G. Dubowchik,et al.  Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin. , 1998, Bioorganic & medicinal chemistry letters.

[69]  R. Weissleder,et al.  A self-immolative reporter for beta-galactosidase sensing. , 2007, Chembiochem : a European journal of chemical biology.

[70]  J. Katzenellenbogen,et al.  A novel connector linkage applicable in prodrug design. , 1981, Journal of medicinal chemistry.

[71]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[72]  Zhiyuan Zhong,et al.  Stimuli-responsive polymersomes for programmed drug delivery. , 2009, Biomacromolecules.

[73]  Roey J. Amir,et al.  Self-immolative dendrimers. , 2003, Angewandte Chemie.

[74]  D. Kerr,et al.  Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. , 2009, International journal of oncology.

[75]  P. Baran,et al.  Sulfhydryl-based dendritic chain reaction. , 2010, Chemical communications.

[76]  Dennis E Discher,et al.  Polymersome carriers: from self-assembly to siRNA and protein therapeutics. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[77]  H. W. Scheeren,et al.  Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy. , 1999, Bioorganic & medicinal chemistry.

[78]  C. Monneret,et al.  Glucuronide prodrugs of hydroxy compounds for antibody directed enzyme prodrug therapy (ADEPT) : A phenol nitrogen mustard carbamate , 1997 .

[79]  A. Romieu,et al.  Development of a new nonpeptidic self-immolative spacer. Application to the design of protease sensing fluorogenic probes. , 2008, Organic letters.

[80]  J. Fréchet,et al.  pH-Responsive copolymer assemblies for controlled release of doxorubicin. , 2005, Bioconjugate chemistry.

[81]  S. Kawakami,et al.  Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations , 2011, Pharmaceutical Research.

[82]  J. Knipe,et al.  Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin. , 1998, Bioorganic & medicinal chemistry letters.

[83]  James B. Mitchell,et al.  Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. , 2002, Cancer research.

[84]  K. Kataoka,et al.  Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. , 2001, Biomacromolecules.

[85]  Scott R White,et al.  Programmable microcapsules from self-immolative polymers. , 2010, Journal of the American Chemical Society.

[86]  R. Müller,et al.  Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. , 2010, Handbook of experimental pharmacology.

[87]  R. Lerner,et al.  Single-triggered trimeric prodrugs. , 2005, Angewandte Chemie.

[88]  D. Shabat,et al.  Self-immolative dendritic probe for direct detection of triacetone triperoxide. , 2008, Chemical communications.

[89]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[90]  Fenghua Meng,et al.  Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[91]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.

[92]  D. McGrath,et al.  Geometric disassembly of dendrimers: dendritic amplification. , 2003, Journal of the American Chemical Society.

[93]  H. W. Scheeren,et al.  "Cascade-release dendrimers" liberate all end groups upon a single triggering event in the dendritic core. , 2003, Angewandte Chemie.

[94]  D. McGrath,et al.  Dendrimer disassembly by benzyl ether depolymerization. , 2003, Journal of the American Chemical Society.

[95]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[96]  H. W. Scheeren,et al.  Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release. , 2001, The Journal of organic chemistry.

[97]  W. Hennink,et al.  Reduction-sensitive polymers and bioconjugates for biomedical applications. , 2009, Biomaterials.

[98]  J. Feijen,et al.  Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. , 2006, Bioconjugate chemistry.

[99]  Atsushi Harada,et al.  Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. , 2003, Angewandte Chemie.

[100]  D. McGrath,et al.  Convergent synthesis of geometrically disassembling dendrimers using Cu(I)-catalyzed C-O bond formation. , 2010, Organic letters.

[101]  W. Tan,et al.  A highly selective ratiometric fluorescent probe for 1,4-dithiothreitol (DTT) detection. , 2010, Organic & biomolecular chemistry.

[102]  María J Vicent,et al.  Polymer therapeutics: clinical applications and challenges for development. , 2009, Advanced drug delivery reviews.

[103]  E. Gillies,et al.  A reduction sensitive cascade biodegradable linear polymer , 2010 .

[104]  Raphael Dumeunier,et al.  Latent fluorophores based on a self-immolative linker strategy and suitable for protease sensing. , 2008, Bioconjugate chemistry.

[105]  H. Haisma,et al.  Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity. , 2010, Bioconjugate chemistry.

[106]  M. Thomas,et al.  Design of self-immolative linkers for tumour-activated prodrug therapy. , 2008, Anti-cancer agents in medicinal chemistry.

[107]  F. Kratz,et al.  2,4-Bis(hydroxymethyl)aniline as a building block for oligomers with self-eliminating and multiple release properties. , 2008, The Journal of organic chemistry.

[108]  J. B. Christensen,et al.  Dendrimers in medicine and biotechnology. New molecular tools , 2006 .

[109]  C. Conover,et al.  Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review. , 2000, Critical reviews in therapeutic drug carrier systems.

[110]  D. Shabat,et al.  Single-triggered AB6 self-immolative dendritic amplifiers. , 2007, Chemistry.

[111]  Yuichi Yamasaki,et al.  PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. , 2008, Journal of the American Chemical Society.

[112]  A. Romieu,et al.  A comparative study of the self-immolation of para-aminobenzylalcohol and hemithioaminal-based linkers in the context of protease-sensitive fluorogenic probes. , 2010, Organic & biomolecular chemistry.

[113]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[114]  P. Senter,et al.  Development of a drug-release strategy based on the reductive fragmentation of benzyl carbamate disulfides , 1990 .

[115]  Marc Dellian,et al.  Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[116]  H. Zhao,et al.  Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds. , 1999, Journal of medicinal chemistry.

[117]  R. Weissleder,et al.  A Self‐Immolative Reporter For β‐Galactosidase Sensing , 2007 .

[118]  P. M. Deckert,et al.  Targeted enzyme prodrug therapies. , 2010, Mini reviews in medicinal chemistry.

[119]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[120]  T. Monks,et al.  The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. , 2002, Current drug metabolism.

[121]  N. Murthy,et al.  Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. , 2005, Bioconjugate chemistry.

[122]  Joel A Swanson,et al.  Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.

[123]  D. Shabat,et al.  Dendritic chain reaction. , 2009, Journal of the American Chemical Society.

[124]  Adah Almutairi,et al.  UV and near-IR triggered release from polymeric nanoparticles. , 2010, Journal of the American Chemical Society.

[125]  K. Ulbrich,et al.  HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[126]  B. Attali,et al.  Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry. , 2006, Bioconjugate chemistry.

[127]  F. Kratz,et al.  Prodrugs of anthracyclines in cancer chemotherapy. , 2006, Current medicinal chemistry.